Nat Immunol:抗病毒天然免疫表观调控获进展

2017-09-01 佚名 中国科学报

《自然—免疫学》杂志8月29日发表了中国医学科学院院长、中国工程院院士曹雪涛研究团队的论文,报道了RNA解旋酶DDX46能够通过RNA去甲基化修饰导致抗病毒效应分子mRNA核滞留、进而抑制抗病毒天然免疫应答的研究结果。

《自然—免疫学》杂志8月29日发表了中国医学科学院院长、中国工程院院士曹雪涛研究团队的论文,报道了RNA解旋酶DDX46能够通过RNA去甲基化修饰导致抗病毒效应分子mRNA核滞留、进而抑制抗病毒天然免疫应答的研究结果。

干扰素在机体抗病毒天然免疫应答中发挥关键性的作用。在病毒感染过程中,干扰素产生的多少与持续时间受到精确调控,以确保机体清除入侵病毒的同时能避免病理性自身免疫损伤。目前关于干扰素表达精确调控的分子机制研究主要集中在天然免疫信号通路蛋白分子,而以细胞核内RNA修饰的方式调控干扰素表达的机制尚不清楚。

曹雪涛院士与中国医学科学院基础所博士后郑青亮以及第二军医大学医学免疫学国家重点实验室教授侯晋联合攻关,针对DEAD-box解旋酶(DDX)家族成员在RNA识别和代谢及其在调控抗病毒天然免疫应答中发挥的重要功能,通过筛选多种DDX家族成员在病毒感染巨噬细胞天然免疫应答中的作用,发现了DDX46能显著抑制病毒感染诱导的干扰素表达。

研究表明,DDX46能结合到抗病毒效应分子mRNA的CCGGUU保守基序上,当病毒感染时DDX46与m6A去甲基化酶ALKBH5结合增加,使得与DDX46结合的抗病毒效应分子mRNA发生去甲基化修饰而导致其核滞留,阻滞了这些抗病毒效应分子的蛋白表达从而降低干扰素产生,最终抑制了抗病毒天然免疫应答反应。

本研究揭示了RNA解旋酶DDX46在细胞核内通过RNA修饰的新方式参与调控抗病毒天然免疫应答,提出了一种新的天然免疫与炎症调控机制,为病毒感染和炎症性疾病的防治提供了新的潜在靶标与思路。

原始出处:

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1882416, encodeId=9431188241628, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Aug 11 02:04:00 CST 2018, time=2018-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1928922, encodeId=4b1a192892288, content=<a href='/topic/show?id=839c90250cc' target=_blank style='color:#2F92EE;'>#表观调控#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90250, encryptionId=839c90250cc, topicName=表观调控)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Fri Sep 15 02:04:00 CST 2017, time=2017-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1292382, encodeId=9ab212923823b, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55471, encryptionId=a3b4554e19d, topicName=抗病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Sun Sep 03 00:04:00 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481285, encodeId=bef614812852d, content=<a href='/topic/show?id=c5534414ee6' target=_blank style='color:#2F92EE;'>#天然免疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44147, encryptionId=c5534414ee6, topicName=天然免疫)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sun Sep 03 00:04:00 CST 2017, time=2017-09-03, status=1, ipAttribution=)]
    2018-08-11 liye789132251
  2. [GetPortalCommentsPageByObjectIdResponse(id=1882416, encodeId=9431188241628, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Aug 11 02:04:00 CST 2018, time=2018-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1928922, encodeId=4b1a192892288, content=<a href='/topic/show?id=839c90250cc' target=_blank style='color:#2F92EE;'>#表观调控#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90250, encryptionId=839c90250cc, topicName=表观调控)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Fri Sep 15 02:04:00 CST 2017, time=2017-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1292382, encodeId=9ab212923823b, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55471, encryptionId=a3b4554e19d, topicName=抗病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Sun Sep 03 00:04:00 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481285, encodeId=bef614812852d, content=<a href='/topic/show?id=c5534414ee6' target=_blank style='color:#2F92EE;'>#天然免疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44147, encryptionId=c5534414ee6, topicName=天然免疫)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sun Sep 03 00:04:00 CST 2017, time=2017-09-03, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1882416, encodeId=9431188241628, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Aug 11 02:04:00 CST 2018, time=2018-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1928922, encodeId=4b1a192892288, content=<a href='/topic/show?id=839c90250cc' target=_blank style='color:#2F92EE;'>#表观调控#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90250, encryptionId=839c90250cc, topicName=表观调控)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Fri Sep 15 02:04:00 CST 2017, time=2017-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1292382, encodeId=9ab212923823b, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55471, encryptionId=a3b4554e19d, topicName=抗病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Sun Sep 03 00:04:00 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481285, encodeId=bef614812852d, content=<a href='/topic/show?id=c5534414ee6' target=_blank style='color:#2F92EE;'>#天然免疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44147, encryptionId=c5534414ee6, topicName=天然免疫)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sun Sep 03 00:04:00 CST 2017, time=2017-09-03, status=1, ipAttribution=)]
    2017-09-03 yahu
  4. [GetPortalCommentsPageByObjectIdResponse(id=1882416, encodeId=9431188241628, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Aug 11 02:04:00 CST 2018, time=2018-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1928922, encodeId=4b1a192892288, content=<a href='/topic/show?id=839c90250cc' target=_blank style='color:#2F92EE;'>#表观调控#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90250, encryptionId=839c90250cc, topicName=表观调控)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Fri Sep 15 02:04:00 CST 2017, time=2017-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1292382, encodeId=9ab212923823b, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55471, encryptionId=a3b4554e19d, topicName=抗病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Sun Sep 03 00:04:00 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481285, encodeId=bef614812852d, content=<a href='/topic/show?id=c5534414ee6' target=_blank style='color:#2F92EE;'>#天然免疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44147, encryptionId=c5534414ee6, topicName=天然免疫)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sun Sep 03 00:04:00 CST 2017, time=2017-09-03, status=1, ipAttribution=)]

相关资讯

Leukemia:中科院广州生物院在CAR-T细胞免疫治疗研究上取得新进展

近日,白血病领域权威杂志Leukemia在线发表了中国科学院广州生物医药与健康研究院李鹏课题组的最新研究成果。该研究构建了包含TLR2共刺激信号的第三代嵌合抗原受体(Chimeric antigen receptor,CAR)分子,并证明了TLR2共刺激信号提高了CAR T细胞杀伤肿瘤的功能。这一研究为天然免疫和适应性免疫在CAR T细胞治疗中的联合效应提供了理论基础,并开拓了CAR分子设计的新思

Oncotarget:孤独症也是免疫性疾病?

近年来,越来越多的研究表明神经、精神类疾病如精神分裂症、阿兹海默症的发生与免疫系统的异常有关。孤独症是一类以刻板动作,社交障碍为核心症状的儿童神经发育性疾病,然而,在儿童孤独症患者中是否有哪些免疫系统的异常,并无系统性的研究。近日来自于四川大学华西第二医院许文明教授课题组与西南交通大学临床医院谢江教授的一项合作研究,针对孤独症儿童的免疫特性及与孤独症儿童的行为异常的关系进行了系统的研究,为这一问题

Elife:科学家发现开启免疫细胞强大肿瘤杀伤力的重要“开关”!

由分子生物学家Leonid Pobezinsky和他的妻子及研究合作者Elena Pobezinskaya在马萨诸塞州阿默斯特大学出版,发表了一些结果,首次显示了一种称为“致命七号”(let-7)的微小RNA分子是如何作为分子控制中心通过将制动器放在其细胞杀伤活动上来指导细胞毒性T淋巴细胞的功能。

Am J Hematol:抗体水平对血栓相关的原发性抗磷脂综合征患者的免疫系统的影响较大

抗磷脂抗体综合征(antiphospholipid syndrome,APS)是指由抗磷脂抗体(antiphospholipid antibody,APL抗体)引起的一组临床征象的总称。APL抗体是一组能与多种含有磷脂结构的抗原物质发生免疫反应的抗体,主要有狼疮抗凝物(lupus anti-coagulant,LA)、抗心磷脂抗体(anti-cardiolipid antibody,ACL抗体)、

Neurology:Nivolumab治疗引发重症肌无力

研究认为,应加强免疫检查点抑制剂治疗后导致的重症肌无力的监控,出现症状后及时干预

Nat Immunol:曹雪涛组Nat Immunol揭示m6A在天然免疫中的重要调控作用

8月28日晚,来自中国医学科学院/北京协和医学院曹雪涛院士课题组在Nature Immunology杂志上在线发表了题为“The RNA helicase DDX46 inhibits innate immunity by entrapping m6A-demethylated antiviral transcripts in the nucleus”的研究论文,首次报道了m6A修饰在抗病毒天然免